510(k) · Cleared
ClearedMulticode - RTX Herpes Simplex Virus 1 and 2 Kit, Model 3711
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Eragen Biosciences · OQO Herpes Simplex Virus Nucleic Acid Amplification Assay
Cleared on May 12, 2010 as substantially equivalent to K971662 (Diagnostic Hybrids, Inc., 1997) after a 96-day review. Its family tree reaches back 1 generation to 1997. 1 of the 9 devices in its family, counting itself, has a Class I recall. 7 later devices descend from it.
- Decided
- May 12, 2010
- Review
- 96 days
- Class
- Class II
- Product code
- OQO
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K971662 (1997). 7 later devices descend from it, 3 citing it directly. 1 of the 9 devices in this family, counting this one, has a Class I recall.
- Root · 1 generation backK971662 Elvis HSV ID/Typing Test SystemDiagnostic Hybrids, Inc. · 1997
- This deviceK100336 Multicode - RTX Herpes Simplex Virus 1 and 2 Kit, Model 3711Eragen Biosciences · 2010
- Descendant · cites it directly · 2 of its ownK140198 Imdx HSV-1/2 for Abbott M2000Intelligent Medical Devices, Inc. · 2014
- Descendant · cites it directly · 1 of its ownK142738 artus HSV-1/2 QS-RGQ MDx KitQiagen · 2014
- Descendant · cites it directly · 1 of its ownK111951 Isoamp HSV AssayBiohelix Corporation · 2011
- Descendant · 2 generations on · 0 of its ownK172509 Sentosa SA201 HSV 1/2 Qualitative PCR TestVela Diagnostics USA, Inc. · 2018
- Descendant · 2 generations on · 0 of its ownK150962 Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackFocus Diagnostics · 2015 · Recalled (Class I)
Showing 5 of 7 descendants. See all descendants
Descendants cleared per year
Class I recalls in this family
- K150962 Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2…2 generations on · 2015
Most influential descendants
Showing 5 of 7 · See all- K140198Imdx HSV-1/2 for Abbott M2000Intelligent Medical Devices, Inc. · 2014 · cites it directly2descendants
- K142738artus HSV-1/2 QS-RGQ MDx KitQiagen · 2014 · cites it directly1descendant
- K111951Isoamp HSV AssayBiohelix Corporation · 2011 · cites it directly1descendant
- K172509Sentosa SA201 HSV 1/2 Qualitative PCR TestVela Diagnostics USA, Inc. · 2018 · 2 generations on0descendants
- K150962Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackFocus Diagnostics · 2015 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K971662 | Elvis HSV ID/Typing Test System | Diagnostic Hybrids, Inc. | 1997 | — |
| 0 (this device) | K100336 | Multicode - RTX Herpes Simplex Virus 1 and 2 Kit, Model 3711 | Eragen Biosciences | 2010 | — |
| +1 | K140198 | Imdx HSV-1/2 for Abbott M2000 | Intelligent Medical Devices, Inc. | 2014 | — |
| +1 | K142738 | artus HSV-1/2 QS-RGQ MDx Kit | Qiagen | 2014 | — |
| +1 | K111951 | Isoamp HSV Assay | Biohelix Corporation | 2011 | — |
| +2 | K172509 | Sentosa SA201 HSV 1/2 Qualitative PCR Test | Vela Diagnostics USA, Inc. | 2018 | — |
| +2 | K150962 | Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack | Focus Diagnostics | 2015 | Class I |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2011 | 1 | 0 |
| 2014 | 3 | 0 |
| 2015 | 2 | 1 |
| 2018 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K971662 | Elvis HSV ID/Typing Test SystemSummary page 1…05 3.0 Device to Which Substantial Equivalence is Claimed Diagnostic Hybrids, Inc. ELVIS® HSV ID/Typing Test System 5 10(k) Number: K97 1662 Confidential EraGen Biosciences, Inc. - 510O(k) Premarket Notification MultiCode®--RTx Heroes Simplex Vimus 1… | 1997 |
What descends from it? (7)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (1 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K150962Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackFocus Diagnostics · 2015 · 2 generations on · ◆ in the 2015 descendants bar of FIG. 11 Class I recall
What does this lineage say?
How does its category compare?
All OQO devicesOQO Herpes Simplex Virus Nucleic Acid Amplification Assay: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · OQO
1in 2018
2026 to Oct 25, outlined.
Median 510(k) review, days · OQO
140in 2015
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OQO
No recall names OQO since 2007.
Adverse event reports per year · OQO
1in 2025
MAUDE reports naming product code OQO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 1 | — | 0 | 0 |
| 2011 | 3 | 81 | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 3 | 87 | 0 | 0 |
| 2015 | 3 | 140 | 0 | 0 |
| 2016 | 0 | — | 0 | 6 |
| 2017 | 1 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 1 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The MultiCode®-RTx HSV 1&2 Kit is a polymerase chain reaction (PCR)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (HSV 1&2) DNA in vaginal lesions. It is indicated for use in the detection and typing of HSV-1 or HSV-2 in vaginal lesion swab specimens from symptomatic female patients as an aid in the diagnosis of genital herpes infection.
Warning: The device is not FDA cleared for the use with cerebral spinal fluid (CSF) or any lesions other than vaginal. This assay is not intended to be used for male penile specimens, for prenatal screening, or for females under the age of 18 years.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K100336 · printed Nov 6, 2026
Cite this page
510(k) Report. “K100336: Multicode - RTX Herpes Simplex Virus 1 and 2 Kit, Model 3711.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100336
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026